262 related articles for article (PubMed ID: 25588142)
21. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.
Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536
[TBL] [Abstract][Full Text] [Related]
22. New developments in serodiagnosis of childhood celiac disease: assay of antibodies against deamidated gliadin.
Prause C; Richter T; Koletzko S; Uhlig HH; Hauer AC; Stern M; Zimmer KP; Laass MW; Probst C; Schlumberger W; Mothes T
Ann N Y Acad Sci; 2009 Sep; 1173():28-35. PubMed ID: 19758128
[TBL] [Abstract][Full Text] [Related]
23. Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease--dermatitis herpetiformis.
Lytton SD; Antiga E; Pfeiffer S; Matthias T; Szaflarska-Poplawska A; Ulaganathan VK; Placek W; Fabbri P; Hall R; Caproni M
Clin Chim Acta; 2013 Jan; 415():346-9. PubMed ID: 23142793
[TBL] [Abstract][Full Text] [Related]
24. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
Comino I; Fernández-Bañares F; Esteve M; Ortigosa L; Castillejo G; Fambuena B; Ribes-Koninckx C; Sierra C; Rodríguez-Herrera A; Salazar JC; Caunedo Á; Marugán-Miguelsanz JM; Garrote JA; Vivas S; Lo Iacono O; Nuñez A; Vaquero L; Vegas AM; Crespo L; Fernández-Salazar L; Arranz E; Jiménez-García VA; Antonio Montes-Cano M; Espín B; Galera A; Valverde J; Girón FJ; Bolonio M; Millán A; Cerezo FM; Guajardo C; Alberto JR; Rosinach M; Segura V; León F; Marinich J; Muñoz-Suano A; Romero-Gómez M; Cebolla Á; Sousa C
Am J Gastroenterol; 2016 Oct; 111(10):1456-1465. PubMed ID: 27644734
[TBL] [Abstract][Full Text] [Related]
25. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease.
Liu E; Li M; Emery L; Taki I; Barriga K; Tiberti C; Eisenbarth GS; Rewers MJ; Hoffenberg EJ
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):293-300. PubMed ID: 17873740
[TBL] [Abstract][Full Text] [Related]
26. Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children.
Basso D; Guariso G; Fogar P; Meneghel A; Zambon CF; Navaglia F; Greco E; Schiavon S; Rugge M; Plebani M
Clin Chem; 2009 Jan; 55(1):150-7. PubMed ID: 18988751
[TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin G antibodies against deamidated-gliadin-peptides outperform anti-endomysium and tissue transglutaminase antibodies in children <2 years age.
Mubarak A; Gmelig-Meyling FH; Wolters VM; Ten Kate FJ; Houwen RH
APMIS; 2011 Dec; 119(12):894-900. PubMed ID: 22085366
[TBL] [Abstract][Full Text] [Related]
28. Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides.
Kasperkiewicz M; Dähnrich C; Probst C; Komorowski L; Stöcker W; Schlumberger W; Zillikens D; Rose C
J Am Acad Dermatol; 2012 Apr; 66(4):583-8. PubMed ID: 21840083
[TBL] [Abstract][Full Text] [Related]
29. The industrial food additive, microbial transglutaminase, mimics tissue transglutaminase and is immunogenic in celiac disease patients.
Matthias T; Jeremias P; Neidhöfer S; Lerner A
Autoimmun Rev; 2016 Dec; 15(12):1111-1119. PubMed ID: 27640315
[TBL] [Abstract][Full Text] [Related]
30. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency.
Lenhardt A; Plebani A; Marchetti F; Gerarduzzi T; Not T; Meini A; Villanacci V; Martelossi S; Ventura A
Dig Liver Dis; 2004 Nov; 36(11):730-4. PubMed ID: 15571003
[TBL] [Abstract][Full Text] [Related]
31. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases.
Gatselis NK; Zachou K; Norman GL; Tzellas G; Speletas M; Gabeta S; Germenis A; Koukoulis GK; Dalekos GN
Clin Chim Acta; 2012 Oct; 413(19-20):1683-8. PubMed ID: 22643316
[TBL] [Abstract][Full Text] [Related]
32. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit.
Kaukinen K; Collin P; Laurila K; Kaartinen T; Partanen J; Mäki M
Scand J Gastroenterol; 2007 Dec; 42(12):1428-33. PubMed ID: 17852878
[TBL] [Abstract][Full Text] [Related]
33. Dynamics of celiac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment.
Sugai E; Nachman F; Váquez H; González A; Andrenacci P; Czech A; Niveloni S; Mazure R; Smecuol E; Cabanne A; Mauriño E; Bai JC
Dig Liver Dis; 2010 May; 42(5):352-8. PubMed ID: 19679520
[TBL] [Abstract][Full Text] [Related]
34. Deamidated gliadin peptide and tissue transglutaminase antibodies in children with coeliac disease: A correlation study.
Saadah OI; Alamri AM; Al-Mughales JA
Arab J Gastroenterol; 2020 Sep; 21(3):174-178. PubMed ID: 32732170
[TBL] [Abstract][Full Text] [Related]
35. Performance of anti-deamidated gliadin peptides antibodies in celiac disease diagnosis.
Sakly W; Mankaï A; Ghdess A; Achour A; Thabet Y; Ghedira I
Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):598-603. PubMed ID: 22436429
[TBL] [Abstract][Full Text] [Related]
36. [Serological diagnosis of celiac disease: anti-gliadin peptide antibodies and tissue anti-transglutaminase].
Piaggio MV; Demonte AM; Sihufe G; Garcilazo S; Esper MC; Wagener M; Aleanzi M
Medicina (B Aires); 1999; 59(6):693-7. PubMed ID: 10752210
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides.
Prince HE
Clin Vaccine Immunol; 2006 Jan; 13(1):150-1. PubMed ID: 16426013
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.
Mozo L; Gómez J; Escanlar E; Bousoño C; Gutiérrez C
J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):50-5. PubMed ID: 22197936
[TBL] [Abstract][Full Text] [Related]
39. IgG anti-tTG responses in different autoimmune conditions differ in their epitope targets and subclass usage.
Comerford R; Kelly J; Feighery C; Byrne G
Mol Immunol; 2015 Oct; 67(2 Pt B):369-76. PubMed ID: 26184652
[TBL] [Abstract][Full Text] [Related]
40. Diagnosing celiac disease: a comparison of human tissue transglutaminase antibodies with antigliadin and antiendomysium antibodies.
Baudon JJ; Johanet C; Absalon YB; Morgant G; Cabrol S; Mougenot JF
Arch Pediatr Adolesc Med; 2004 Jun; 158(6):584-8. PubMed ID: 15184223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
